The American Lung Association in Ohio has awarded the "Emerging Respiratory Pathogens Award" grant to Dr. Yohannes Mebratu from Ohio State University. Dr. Mebratu's research will focus on ARIH2 enzymes, which are known for breaking down a protein that exacerbates influenza severity by aiding virus replication. This research aims to develop new treatments as resistance to antiviral drugs continues to rise.
Brittany Sinzinger, Executive Director at the Lung Association, stated, “In 2024, the American Lung Association is celebrating 120 years of funding lifesaving research. Lung Association researchers have achieved major milestones, including helping end the devastation of tuberculosis in this country, saving millions of lives of premature babies with respiratory distress syndrome (RDS), supporting research on COVID-19 and much more.” She added that given influenza's widespread impact annually, advancing research into new ways to combat the virus remains crucial.
The American Lung Association Research Institute has announced a $22 million investment over the past year for lung health research. This makes it one of the largest programs dedicated to this field in the United States. The institute funded 144 grants across various categories such as Allergic Respiratory Diseases, Respiratory Health Equity Research, and Interstitial Lung Disease.
Research projects funded by the association undergo rigorous scientific peer review to ensure they address complex issues related to lung health effectively.
The association is currently accepting applications for its 2025-2026 research awards cycle. Interested parties can find more information about active funding opportunities and new grant awardees on their website.
